Yuli Volvik, Ph.D.

Senior Client Strategist


Dr. Yuli Volovik received her Ph.D. in Biochemistry and Molecular Biology from the Hebrew University of Jerusalem.

In her research, she focused on the aging process and Neurodegenerative diseases. Dr. Yuli Volovik studied the mechanisms that link the aging process to late onset disorders that are associated with toxic protein aggregation at the molecular and cellular levels. A key finding was the discovering of the differential regulation of the Heat Shock Factor 1 and DAF-16 by a neuronal network in the insulin/IGF-1 signaling (IIS) pathway which influences the ability of the organism to cope various kinds of stress including proteotoxicity.

Dr. Volovik is the recipient of many awards and honors including M.Sc. magna cum laude from the Faculty of Medicine in the Hebrew University of Jerusalem. The prize for excellence in M.Sc. research from the Faculty of Medicine in the Hebrew University of Jerusalem and the Aging Cell runner-up best paper. In addition, Dr. Volovik has authored and co-authored numerous publications.

Her knowledge in Biochemistry and Molecular Biology enables Dr. Volovik to utilize this experience for a profound understanding of the scientific processes to identify the best suitable non-dilutive sources of funding for each client.

Dr. Volovik is now applying her scientific knowledge to devise granting strategies and match FreeMind’s clients with the most appropriate non-dilutive funding sources.